Effect of endurance and strength exercise on release of brain natriuretic peptide

Journal of Cardiovascular Disease Research

Volumn 3, Issue 1, 2012, Pages 22-25

  Bordbar, Somayeh ^a   Bigi, Mohammad Ali ^b   Aslani, Amir ^b   Rahimi, Eskandar ^a   Ahmadi, Nader ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain natriuretic peptide; endurance exercise; strength exercise

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANABOLIC AGENT;

ADULT; ARTICLE; BODY BUILDING; CONTROLLED STUDY; ENDURANCE TRAINING; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE TENSION; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SECRETION; RESISTANCE TRAINING; SEDENTARY LIFESTYLE;

EID: 84856417161     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.91599     Document Type: Article

References (13)

1. Maisel A. B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure. J Card Fail 2001;7:183-93. (Pubitemid 32554112)
2. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004;6:257-60. (Pubitemid 38253043)
3. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002;105: 595-601. (Pubitemid 34123434)
4. Almeida SS, Azevedo A, Castro A, Friões F, Freitas J, Ferreira A, et al. B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes. Cardiology 2002;98:113-5. (Pubitemid 36158570)
5. Mizuno Y, Yoshimura M, Harada E, Nakayama M, Sakamoto T, Shimasaki Y, et al. Plasma levels of A and B type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 2000;86:1036-40.
6. La Villa G, Stefani L, Lazzeri C, Zurli C, Guerra CT, Barletta G, et al. Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension 1995;26:628-33.
7. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13. (Pubitemid 28020159)
8. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptides from rat ventricular myocardium: Effect of stretching. Endocrinology 1993;132:1961-70. (Pubitemid 23133241)
9. Leers MP, Schepers R, Baumgarten R. Effect of a long distance run on cardiac markers in healthy athletes. Clin Chem Lab Med 2006;44:999-1003. (Pubitemid 44155871)
10. Neumayr G, Pfister R, Mitterbauer G, Eibl G, Hoertnagl H. Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am J Cardiol 2005;96:732-5. (Pubitemid 41207322)
11. Middleton N, Shave R, George K, Whyte G, Forster J, Oxborough D, et al. Novel application of flow propagation velocity and ischaemia modified albumin in analysis of postexercise cardiac function in man. Exp Physician 2006; 91:511-9.
12. Berent R, von Duvillard SP, Crouse SF, Auer J, Green JS, Sinzinger H, et al. Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide. Eur J Cardiovasc Prev Rehabil 2009;16:603-8.
13. Minami J, Nishikimi T, Matsuoka H. Plasma brain natriuretic peptide and N-terminal pro atrial natriuretic peptide levels in obese patients: A cause or result of hypertension? Circulation 2004;110:e76.